Danish drugmaker teams with US biotech to develop oral obesity and metabolic drugs as shares fall 63% over 12 months.

Spero Therapeutics’ oral antibiotic tebipenem shows Phase 3 success and supports GSK’s NDA resubmission. Click here to read my latest analysis of SPRO stock.

Declares a regular quarterly cash dividend of $0.20 per share of common stock for the fourth quarter of 2025, payable on March 6, 2026.

Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...

HUNTSVILLE, Ala. (WHNT) – You’ve probably heard a friend or celebrity talk about IV therapy and how they feel amazing after receiving it. But what is it, and what are the health benefits? Located in ...

Intravenous (IV) fluid therapy isn’t a cure-all for hangovers. It may help relieve certain symptoms linked to dehydration, but it doesn’t address all possible underlying factors that can contribute to ...

Check subject expert verified answers for CBSE Class 12 Geography exam. This can help students calculate probable scores after the easy-to-moderate CBSE Geography board exam held on February 26.

FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Phase 3 STRIVE-ON ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced the ...

Allspring Premier Large Company Growth Fund lagged its benchmark in Q4 2025 but posted strong yearly gains. Read the full ...

Radimed Corp (IRMD) reports a 17% revenue increase and outlines future growth plans amid challenges in transitioning to new product lines.

Powerful mix of both trader and investor packs with timely expert advice. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...